The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis

Journal of Cardiology

Volumn 51, Issue 3, 2008, Pages 179-188

  Matoh, Fumitaka ^a   Satoh, Hiroshi ^b   Shiraki, Katsunori ^b   Odagiri, Keiichi ^b   Saitoh, Takeji ^b   Urushida, Tsuyoshi ^b   Katoh, Hideki ^b   Takehara, Yasuo ^c   Sakahara, Harumi ^a   Hayashi, Hideharu ^b  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hamamatsu University School of Medicine   (Japan)

^c NONE

Author keywords

Delayed enhancement; Left ventricular function; Magnetic resonance imaging; Sarcoidosis; Single photon emission computed tomography

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GALLIUM 67; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE PERFUSION; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SARCOIDOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADRENAL CORTEX HORMONES; ADULT; AGED; CARDIOMYOPATHIES; FEMALE; FLUORODEOXYGLUCOSE F18; GALLIUM RADIOISOTOPES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SARCOIDOSIS; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 44149097815     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.03.002     Document Type: Article

References (42)

1. H. Valantine W.J. Mckenna P. Nihoyannpoulos A. Mitchell R.A. Foale M.J. Davies Sarcoidosis: a pattern of clinical and morphological presentation Br Heart J 57 1987 256 263
2. K.J. Silverman G.M. Hutchins B.H. Bulkley Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis Circulation 58 1978 1204 1211
3. V. Abeler Sarcoidosis of the cardiac conducting system Am Heart J 97 1979 701 707
4. O. Vignaux R. Dhote D. Duboc P. Blanche J.Y. Devaux S. Weber Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study J Comput Assist Tomogr 26 2002 762 767
5. K. Iwai M. Sekiguti Y. Hosoda R.A. DeRemee H.D. Tazelaar O.P. Sharma Racial difference in cardiac sarcoidosis incidence observed at autopsy Sarcoidosis 11 1994 26 31
6. K. Iwai T. Tachibana T. Takemura Y. Matsui M. Kitaichi Y. Kawabata Pathological studies on sarcoidosis autopsy I. epidemiological features of 320 cases in Japan Acta Pathol Jpn 43 1993 372 376
7. O.P. Sharma Cardiac and neurologic dysfunction in sarcoidosis Clin Chest Med 18 1997 813 825
8. Y. Yazaki M. Isobe M. Hiroe S. Morimoto S. Hiramitsu T. Nakano Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with predonisone Am J Cardiol 88 2001 1006 1010
9. O.P. Sharma A. Maheshwari K. Thaker Myocardial sarcoidosis Chest 103 1993 253 258
10. K. Okayama C. Kurata K. Tawarahara Y. Wakabayashi K. Chida A. Sato Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis Chest 107 1995 330 334
11. A. Tada 67Gallium whole body scintigraphy and single photon emission computed tomography (SPECT) in sarcoidosis Nippon Rinsho 60 2002 1753 1758 [in Japanese with English abstract]
12. H. Yamagishi N. Shirai M. Takagi M. Yoshiyama K. Akioka K. Takeuchi Identification of cardiac sarcoidosis with 13N-NH3/18F-FDG PET J Nucl Med 44 2003 1030 1036
13. W. Okumura T. Iwasaki T. Toyama T. Iso M. Arai N. Oriuchi Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis J Nucl Med 45 2004 1989 1998
14. A. Wagner H. Mahrholdt T.A. Holly M.D. Elliott M. Regenfus M. Parker Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study Lancet 361 2003 374 379
15. F. Matoh H. Hayashi H. Terada H. Satoh H. Katoh T. Urushida Usefulness of delayed enhancement magnetic resonance imaging for detecting cardiac rupture caused by small myocardial infarction in a case of cardiac tamponade Circ J 69 2005 1556 1559
16. F. Matoh H. Satoh K. Shiraki T. Urushida H. Katoh Y. Takehara Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy J Cardiac Fail 13 2007 372 379
17. K. Riedy M.R. Fisher N. Belic D. Koenigsberg MR images of myocardial sarcoidosis Am J Roentgenol 151 1988 915 916
18. M. Chandra M.E. Siverman J. Oshinski R. Pettigrew Diagnosis of cardiac sarcoidosis aided by MRI Chest 110 1996 562 565
19. T. Shimada K. Shimada T. Sakane K. Ochiai H. Tsukihashi M. Fukui Diagnosis of cardiac sarcoidosis and evaluation of effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging Am J Med 110 2001 520 527
20. O. Vignaux R. Dhote D. Duboc P. Blanche D. Dusser S. Waber Clinical significance of myocardial magnetic resonance abnormalities in patients with sarcoidosis. A 1-year follow-up study Chest 122 2002 1895 1901
21. P. Paule L. Braem P. Heno J. Miltgen D. Verrot L. Fourcade Diagnosis of cardiac sarcoidosis and follow-up of 24 consecutive patients Rev Med Intern 25 2004 357 362
22. R. Dhote O. Vignaux P. Blanche D. Duboc D. Dusser A. Brezin Value of MRI for the diagnosis of cardiac involvement in sarcoidosis Rev Med Intern 24 2003 151 157
23. O. Vignaux Cardiac sarcoidosis: spectrum of MRI features Am J Roentgenol 184 2005 249 254
24. E. Tadamura M. Yamamuro S. Kubo S. Kanao T. Saga M. Harada Effectiveness of delayed enhanced MRI for identification of cardiac sarcoidosis: comparison with radionuclide imaging Am J Roentgenol 185 2005 110 115
25. J.P. Smedema G. Snoep M.P.G. Kroonenburgh R.J. Van Geuns W.R.M. Dassen A.P.M. Gorgels Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis J Am Coll Cardiol 45 2005 1683 1690
26. Y. Hiraga Proposal by the Specific Diffuse Pulmonary Disease Research Group 1989 Sarcoidosis Division by the Japanese Ministry of Health and Welfare p. 13–6 [in Japanese]
27. Hiraga H, Hiroe M, Iwai K, Guideline for dagnosis of cardiac sarcoidosis: study report on diffuse pulmonary diseases by the Japanese Ministry of Health and Welfare; 1993: p. 23–4 [in Japanese].
28. T. Sugi H. Satoh A. Uehara H. Katoh H. Terada M. Matsunaga Usefulness of stress myocardial perfusion imaging for evaluating asymptomatic patients after coronary stent implantation Circ J 68 2004 462 466
29. T. Torizuka S. Nobezawa S. Momiki N. Kasamatsu T. Kanno E. Yoshikawa Short dynamic FDG-PET imaging protocol for patients with lung cancer Eur J Nucl Med 27 2000 1538 1542
30. D.S. Berman H. Kiat J.D. Friedman F.P. Wang K. Van Train L. Matzer Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial prefusion single-photon emission computed tomography: a clinical validation study J Am Coll Cardiol 22 1993 1455 1464
31. B. Lorell E.L. Aldeman J.W. Mason Cardiac sarcoidosis: diagnosis with endomyocardial biopsy and treatment with corticosteroids Am J Cardiol 42 1978 143 146
32. A. Uemura S. Morimoto S. Hiramitsu Y. Kato T. Ito H. Hishida Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies Am Heart J 138 1999 299 302
33. R. Edelman Contrast-enhanced MR imaging of the heart: overview of the literature Radiology 232 2004 653 668
34. J.C.C. Moon W.J. McKenna J.A. McCrohon P.M. Elliott G.C. Smith D.J. Pennell Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567
35. T. Takemura Epithelioid cell granuloma in sarcoidosis: light and electron microscopic morphology Nippon Rinsho 60 2002 1704 1713 [in Japanese with English abstract]
36. L. Van Hoe M. Vanderhyden Ischemic cardiomyopathy: value of different MRI techniques for prediction of functional recovery after revascularization Am J Roentgenol 182 2004 95 100
37. B.R. Line G.W. Hunninghake B.A. Keogh K.A. Jones G.S. Johnston R.G. Crystal Gallium-67 scanning to stage the alveolitis of sarcoidosis: correlation with clinical studies, pulmonary function studies, and bronchoalveolar lavage Am Rev Respir Dis 123 1981 440 446
38. A.N. Leug M.W. Brauner N. Caillat-Vigneron D. Valeyre P. Grenier Sarcoidosis activity: correlation of HRCT findings with those of 67Ga scanning, bronchoalveolar lavage, and serum angiotensin-converting enzyme assay J Comput Assist Tomogr 22 1998 229 234
39. A. Uemura S. Morimoto Cardiac sarcoidosis Nippon Rinsho 60 2002 1794 1800 [in Japanese with English abstract]
40. R.J. Kim E.L. Chen J.A.C. Lima R.M. Judd Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after Acute reperfused infarction Circulation 94 1996 3318 3326
41. S.J. Flacke S.E. Fischer C.H. Lorenz Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction Radiology 218 2001 703 710
42. E. Tadamura M. Yamamuro S. Kubo S. Kanao R. Hosokawa T. Kimura Multimodality imaging of cardiac sarcoidosis before and after steroid therapy Circulation 113 2006 e771 e773